OIG bulletin – Talk Bio

Actionable Insights Powered by AI

HHS Issues Guidance to Shield Pharma from Anti-Kickback Violations in TrumpRx Direct-to-Consumer Drug Sales

TrumpRx; HHS; anti-kickback statute; direct-to-consumer; prescription drugs; OIG bulletin